Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
DYNAVAX TECH Add to My Watchlist (NSDQ: DVAX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Dynavax 1.49 +0.05 (+3.47%) 230,232
2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753 US
(510) 848-5100
(510) 848-5694 fax
www.dynavax.com
CEO Dr. Dino Dina, M.D.
Auditor ERNST & YOUNG LLP
Exchange Traded NQ
ISIN Number US2681581029
CIK Number 1029142
NAICS Code 325412
Business Summary
A clinical-stage biopharmaceutical company, which discovers and develops a pipeline of novel Toll-like Receptor product candidates.
Number of Employees 155
Share Fundamentals
Market Cap 61.51M
Shares Outstanding 41.28M
Float 35.85M
Short Interest 843.92K
Financial Strength
Revenue (TTM) $50,074,000
Earnings (TTM) $1,795,000
Quick Ratio 4.1:1
Current Ratio 4.3:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin 1.1%
Profit Margin -4.7%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs